tiprankstipranks
Decoy Therapeutics (DCOY)
NASDAQ:DCOY
US Market
DCOY
Decoy Therapeutics
RESEARCH TOOLSreports
Want to see DCOY full AI Analyst Report?

Decoy Therapeutics (DCOY) Income Statement

636 Followers

Decoy Therapeutics Income Statement

Last quarter (Q1 2026), Decoy Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Decoy Therapeutics's net income was $-2.22M. See Decoy Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -8.52M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.10M$ 5.73M$ 12.89M$ 31.84M$ 12.81M
Depreciation and Amortization
$ 0.00$ 4.42K$ 10.05K$ 6.68K$ 19.18K
EBITDA
$ -12.61M$ -5.73M$ -12.88M$ -22.97M$ -12.79M
Operating Income
$ -12.61M$ -5.73M$ -12.89M$ -31.84M$ -12.81M
Other Income/Expenses
$ 95.47K$ 158.54K$ 352.25K$ 233.18K$ 44.69K
Pretax Income
$ -12.52M$ -5.58M$ -12.54M$ -31.61M$ -12.77M
Net Income
$ -12.52M$ -5.58M$ -12.54M$ -31.61M$ -12.77M
Per Share Metrics
Basic EPS
$ -25.99$ -86.92$ -461.04$ -1.79K$ -926.01
Diluted EPS
$ -25.99$ -86.92$ -461.04$ -1.79K$ -926.01
Weighted Average Shares Outstanding
 481.59K 64.15K 27.20K 17.70K 13.79K
Weighted Average Shares Outstanding (Diluted)
 481.59K 64.15K 27.20K 17.70K 13.79K
Currency in USD

Decoy Therapeutics Earnings and Revenue History